re: Let’s talk weed stocks in this thread

quote:

---

As a follow up to my post - I think the difficulty in cloning well at volume is both a good thing for lvvv as far as marketability and their niche. However it could also be a bad thing if they are not going it correctly abd depending on their plan to meet the volume it requires.

---

LVVV has no experience, no capital, and limited at best employees. The premise pushed in this thread of thousands of clones being moved out was implicitly based on the fact that it could be done rather easily - hence you can hire a horticulturist that ran basically a now defunct clone company before - snap your fingers - and with no cash be throwing off thousands of clones just like that.

The rest of the weed world just couldn't see how easy it was and thus while they focused on developing 100,000 Sq foot plus cultivation farms, they couldn't see the easy money was buying some pods and just pushing out massive numbers of clones.

The contrarians in this thread have consistently asked - what is the secret sauce? - what makes LVVV special in that they can go from literally nothing to the point where a $30 million market cap is a gross understatement (per the longs here). Why if you can set up a clone shop worth hundreds of millions with basically no meaningful capital and no experience did no one else do it. Well the rest of the world is just not as smart as them. There is this inherent belief in a penny stock failure (Hodson) who has bounced from business idea to business idea with no public market success.

I maintain the play for the longs is still coming as they will report revenue (not much when they file their now late - shocker - annual report as that only will cover 12/31/19 but when they file Q1). The uplist failure (been over a year since they first announced their plan to uplist (4/5/18)) is unlikely until they catch up their filings (never mind fix their old filings). Again, evidence how bad management is. But that could also be a catalyst if it happens.

But the long term argument of millions of revenue a month.... just not in the cards.